Regions Financial Corp Teva Pharmaceutical Industries LTD Transaction History

Regions Financial Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	BUY	$8.12 - $10.63 $100,639 - $131,748	12,394 New	12,394 $129,000
Q2 2019 Jul 19, 2019	SELL	$8.12 - $15.72 $55,289 - $107,037	-6,809 Closed	0 $0
Q1 2019 Apr 19, 2019	BUY	$15.58 - $20.01 $218 - $280	14 Added 0.21%	6,809 $107,000
Q4 2018 Jan 28, 2019	SELL	$14.59 - $23.84 $4,960 - $8,105	-340 Reduced 4.77%	6,795 $104,000
Q3 2018 Oct 22, 2018	SELL	$21.06 - $25.65 $44,878 - $54,660	-2,131 Reduced 23.0%	7,135 $153,000
Q2 2018 Jul 26, 2018	SELL	$16.77 - $24.71 $13,667 - $20,138	-815 Reduced 8.08%	9,266 $225,000
Q1 2018 Apr 18, 2018	SELL	$16.68 - $22.07 $24,636 - $32,597	-1,477 Reduced 12.78%	10,081 $172,000
Q4 2017 Jan 18, 2018	BUY	$11.23 - $19.1 $2,672 - $4,545	238 Added 2.1%	11,558 $219,000
Q3 2017 Oct 23, 2017	BUY	$15.41 - $32.17 $174,441 - $364,164	11,320	11,320 $200,000

624

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Regions Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Regions Financial Corp with notifications on news.